Literature DB >> 28540066

Cine-CMR partial voxel segmentation demonstrates increased aortic stiffness among patients with Marfan syndrome.

Parmanand Singh1, Zaid Almarzooq1, Noel C F Codell2, Yi Wang1, Mary J Roman1, Richard B Devereux1, Jonathan W Weinsaft1.   

Abstract

BACKGROUND: Standard cine-cardiac magnetic resonance (CMR) imaging is commonly used to evaluate cardiac structure, geometry and function. Prior studies have shown that automated segmentation via partial voxel interpolation (PVI) accurately quantifies phantom-based cardiac chamber volumes and necropsy left ventricular myocardial mass. Despite this, the applicability and usefulness of PVI in the determination of physiologic parameters of the aorta such as aortic stiffness has yet to be investigated.
METHODS: Routine CMR was conducted with a 1.5T (GE) scanner with pulse sequences similar to that of standard CMR (parameters: TR 3.4 msec, TE 1.14 msec, flip angle 60°, temporal resolution ~30-40 msec). Views were obtained in standard cardiac-oriented longitudinal or axial views (2, 3 and 4 chambers). Within non-dilated regions of the descending thoracic aorta, aortic area was quantified via a novel PVI automated process (LV-METRIC), which discerns relative amounts of blood pool in each voxel. Aortic stiffness, as calculated from brachial artery pulse pressure and aortic area at maximal and minimal dimensions, was evaluated in 60 total segments (one segment per patient). All segments were in the descending aorta and were not aneurysmal.
RESULTS: Sixty patients in total were studied, including 50 that had genetically-related aortic disorder [35 bicuspid aortic valve (BAV), 15 Marfan syndrome (MFS)]. Ten normal controls without aortic disease were included for comparison purposes. All patients (n=60) had evaluable CMR images for assessment of the descending aorta with use of automated segmentation. Patients with BAV and MFS were similar to controls in age, systolic blood pressure, brachial artery pulse pressure, smoking status or hypercholesterolemia (all P=NS). There were more women (P<0.001), lower body mass index (P=0.008), and greater height (P<0.001) in the MFS cohort compared to BAV and controls. Descending aortic area in either systole (maximal) or diastole (minimal) was similar among all three cohorts. However, change in aortic area (ΔArea) throughout the cardiac cycle was substantially lower in MFS than control subjects (P<0.001). In contrast, change in aortic area throughout the cardiac cycle was not significantly different between BAV vs. controls (P=0.62). Aortic stiffness was increased among MFS patients versus control subjects (P=0.014). When comparing MFS to BAV subjects, a comparable trend was observed (P=0.09). No statistical difference was evident in aortic stiffness in patients with BAV versus control subjects (P=0.29).
CONCLUSIONS: The application of PVI to standard CMR imaging can assess abnormal descending aorta functional indices in normal caliber segments in MFS subjects. Future prospective studies with larger subject populations are warranted to further determine the overall utility of automated aortic segmentation as a possible early biomarker of aortic dysfunction before overt dilatation.

Entities:  

Keywords:  Marfan syndrome (MFS); aorta; arterial stiffness; magnetic resonance imaging (MRI)

Year:  2017        PMID: 28540066      PMCID: PMC5422665          DOI: 10.21037/jtd.2017.04.02

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  23 in total

1.  Magnetic resonance imaging evaluation of aortic elastic properties as early expression of Marfan syndrome.

Authors:  R Fattori; L Bacchi Reggiani; G Pepe; G Napoli; C Bnà; F Celletti; L Lovato; G Gavelli
Journal:  J Cardiovasc Magn Reson       Date:  2000       Impact factor: 5.364

Review 2.  Aortic dissection: a 250-year perspective.

Authors:  Frank J Criado
Journal:  Tex Heart Inst J       Date:  2011

Review 3.  Marfan's syndrome.

Authors:  Daniel P Judge; Harry C Dietz
Journal:  Lancet       Date:  2005-12-03       Impact factor: 79.321

4.  Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders.

Authors:  Gail D Pearson; Richard Devereux; Bart Loeys; Cheryl Maslen; Dianna Milewicz; Reed Pyeritz; Francesco Ramirez; Daniel Rifkin; Lynn Sakai; Lars Svensson; Andy Wessels; Jennifer Van Eyk; Harry C Dietz
Journal:  Circulation       Date:  2008-08-12       Impact factor: 29.690

5.  Atenolol versus Losartan in Marfan's Syndrome.

Authors:  Ronald V Lacro; Harry C Dietz; Lynn Mahony
Journal:  N Engl J Med       Date:  2015-03-05       Impact factor: 91.245

6.  Aortic biomechanics by magnetic resonance: early markers of aortic disease in Marfan syndrome regardless of aortic dilatation?

Authors:  Gisela Teixido-Tura; Alban Redheuil; Jose Rodríguez-Palomares; Laura Gutiérrez; Violeta Sánchez; Alberto Forteza; Joao A C Lima; David García-Dorado; Artur Evangelista
Journal:  Int J Cardiol       Date:  2013-11-25       Impact factor: 4.164

7.  Improved left ventricular mass quantification with partial voxel interpolation: in vivo and necropsy validation of a novel cardiac MRI segmentation algorithm.

Authors:  Noel C F Codella; Hae Yeoun Lee; David S Fieno; Debbie W Chen; Sandra Hurtado-Rua; Minisha Kochar; John Paul Finn; Robert Judd; Parag Goyal; Jesse Schenendorf; Matthew D Cham; Richard B Devereux; Martin Prince; Yi Wang; Jonathan W Weinsaft
Journal:  Circ Cardiovasc Imaging       Date:  2011-11-21       Impact factor: 7.792

8.  Rapid and accurate left ventricular chamber quantification using a novel CMR segmentation algorithm: a clinical validation study.

Authors:  Noel C F Codella; Matthew D Cham; Richard Wong; Christopher Chu; James K Min; Martin R Prince; Yi Wang; Jonathan W Weinsaft
Journal:  J Magn Reson Imaging       Date:  2010-04       Impact factor: 4.813

9.  Aortic size in acute type A dissection: implications for preventive ascending aortic replacement.

Authors:  Landi M Parish; Joseph H Gorman; Sophia Kahn; Theodore Plappert; Martin G St John-Sutton; Joseph E Bavaria; Robert C Gorman
Journal:  Eur J Cardiothorac Surg       Date:  2009-02-23       Impact factor: 4.191

10.  Aortic Dissection in Patients With Genetically Mediated Aneurysms: Incidence and Predictors in the GenTAC Registry.

Authors:  Jonathan W Weinsaft; Richard B Devereux; Liliana R Preiss; Attila Feher; Mary J Roman; Craig T Basson; Alexi Geevarghese; William Ravekes; Harry C Dietz; Kathryn Holmes; Jennifer Habashi; Reed E Pyeritz; Joseph Bavaria; Karianna Milewski; Scott A LeMaire; Shaine Morris; Dianna M Milewicz; Siddharth Prakash; Cheryl Maslen; Howard K Song; G Michael Silberbach; Ralph V Shohet; Nazli McDonnell; Tabitha Hendershot; Kim A Eagle; Federico M Asch
Journal:  J Am Coll Cardiol       Date:  2016-06-14       Impact factor: 24.094

View more
  3 in total

1.  Sex Chromosome Complement Defines Diffuse Versus Focal Angiotensin II-Induced Aortic Pathology.

Authors:  Yasir Alsiraj; Sean E Thatcher; Eric Blalock; Bradley Fleenor; Alan Daugherty; Lisa A Cassis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-02       Impact factor: 8.311

2.  Unreliable Estimation of Aortic Pulse Wave Velocity Provided by the Mobil-O-Graph Algorithm-Based System in Marfan Syndrome.

Authors:  Paolo Salvi; Giulia Furlanis; Andrea Grillo; Alessandro Pini; Lucia Salvi; Susan Marelli; Matteo Rovina; Francesco Moretti; Raffaella Gaetano; Inês Pintassilgo; Andrea Faini; Bruno Fabris; Renzo Carretta; Gianfranco Parati
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

3.  Prosthetic aortic graft replacement of the ascending thoracic aorta alters biomechanics of the native descending aorta as assessed by transthoracic echocardiography.

Authors:  Maria C Palumbo; Lisa Q Rong; Jiwon Kim; Pedram Navid; Razia Sultana; Jonathan Butcher; Alberto Redaelli; Mary J Roman; Richard B Devereux; Leonard N Girardi; Mario F L Gaudino; Jonathan W Weinsaft
Journal:  PLoS One       Date:  2020-03-12       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.